Literature DB >> 11299572

The cost effectiveness of larval therapy in venous ulcers.

J Wayman1, V Nirojogi, A Walker, A Sowinski, M A Walker.   

Abstract

The treatment of necrotic ulcers involves considerable nursing time and expense. The current standard treatment involves repeated application of hydrogels. Larval debridement therapy (LDT) has been shown anecdotally to clear ulcers of necrotic slough but has never been compared directly with 'modern' therapies. The aim of this study has been to compare LDT with hydrogel dressings in the treatment of necrotic venous ulcers. 12 patients with sloughy venous ulcers were randomised to receive either LDT or the control therapy--a hydrogel. Effective debridement occurred with a maximum of one larval application in 6/6 patients. 4/6 patients [corrected] in the hydrogel group still required dressings at one month. The median cost of treatment of the larval group was 78.64 Pounds compared with 136.23 Pounds for the control treatment group (p < 0.05). The study confirms both the clinical efficacy and cost effectiveness of larval therapy in the debridement of sloughy venous ulcers.

Entities:  

Mesh:

Year:  2000        PMID: 11299572     DOI: 10.1016/s0965-206x(00)80036-4

Source DB:  PubMed          Journal:  J Tissue Viability        ISSN: 0965-206X            Impact factor:   2.932


  21 in total

Review 1.  The efficacy of maggot debridement therapy--a review of comparative clinical trials.

Authors:  Kian Zarchi; Gregor B E Jemec
Journal:  Int Wound J       Date:  2012-01-17       Impact factor: 3.315

2.  Assessment of the antimicrobial properties of maggots.

Authors:  Leon Margolin; Philip Gialanella
Journal:  Int Wound J       Date:  2010-04-23       Impact factor: 3.315

Review 3.  Larval therapy from antiquity to the present day: mechanisms of action, clinical applications and future potential.

Authors:  Iain S Whitaker; Christopher Twine; Michael J Whitaker; Mathew Welck; Charles S Brown; Ahmed Shandall
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

4.  Clinical study of Maggot therapy for Fournier's gangrene.

Authors:  Alicia Fonseca-Muñoz; Hugo E Sarmiento-Jiménez; Rafael Pérez-Pacheco; Patricia J Thyssen; Ronald A Sherman
Journal:  Int Wound J       Date:  2020-07-21       Impact factor: 3.315

5.  Sterilization of blow fly eggs, Chrysomya megacephala and Lucilia cuprina, (Diptera: Calliphoridae) for maggot debridement therapy application.

Authors:  Kwankamol Limsopatham; Phadungkiat Khamnoi; Kabkaew L Sukontason; Dheerawan Boonyawan; Tarinee Chaiwong; Kom Sukontason
Journal:  Parasitol Res       Date:  2017-03-30       Impact factor: 2.289

Review 6.  Maggot therapy takes us back to the future of wound care: new and improved maggot therapy for the 21st century.

Authors:  Ronald A Sherman
Journal:  J Diabetes Sci Technol       Date:  2009-03-01

Review 7.  Debridement for venous leg ulcers.

Authors:  Georgina Gethin; Seamus Cowman; Dinanda N Kolbach
Journal:  Cochrane Database Syst Rev       Date:  2015-09-14

8.  Exploring patient perceptions of larval therapy as a potential treatment for venous leg ulceration.

Authors:  Karen Spilsbury; Nicky Cullum; Jo Dumville; Susan O'Meara; Emily Petherick; Carl Thompson
Journal:  Health Expect       Date:  2008-06       Impact factor: 3.377

9.  Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

Authors:  Jo C Dumville; Gill Worthy; J Martin Bland; Nicky Cullum; Christopher Dowson; Cynthia Iglesias; Joanne L Mitchell; E Andrea Nelson; Marta O Soares; David J Torgerson
Journal:  BMJ       Date:  2009-03-19

10.  Cost effectiveness analysis of larval therapy for leg ulcers.

Authors:  Marta O Soares; Cynthia P Iglesias; J Martin Bland; Nicky Cullum; Jo C Dumville; E Andrea Nelson; David J Torgerson; Gill Worthy
Journal:  BMJ       Date:  2009-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.